Skip to main content
. 2022 Nov 15;194:110157. doi: 10.1016/j.diabres.2022.110157

Table 2C.

Demographics of the prediabetes cohort with ondansetron comparator * Native Hawaiian or Other Pacific Islander.

All patients On Ondansentron On Metformin p-value
n 8015 7618 397
DEMOGRAPHICS
age 57.82 (16.14) 58.41 (15.98) 46.80 (15.09) 0
BMI 33.22 (8.78) 32.85 (8.62) 37.88 (9.41) 0
length of stay 10.66 (49.07) 10.75 (47.57) 8.91 (72.00) 0.466
INPATIENT/OUTPATIENT
Inpatient or ED 6614 (82.5%) 6544 (85.9%) 70 (17.6%) 0
GENDER 0
Male 3346 (41.7%) 3235 (42.5%) 111 (28.0%)
Female 4661 (58.2%) 4375 (57.4%) 286 (72.0%)
RACE 0.07
White 4738 (59.1%) 4515 (59.3%) 223 (56.2%)
Black or African American 1873 (23.4%) 1781 (23.4%) 92 (23.2%)
Asian 228 (2.8%) > 20 < 20
Other > 20 > 20 < 20
NHOPI* 20 (0.2%) < 20 < 20
ETHNICITY 0
Hispanic or Latino 1275 (17.3%) 1163 (16.6%) 112 (30.4%)
Not Hispanic or Latino 6088 (82.7%) 5831 (83.4%) 257 (69.6%)
CCI > 1 2583 (32.2%) 2520 (33.1%) 63 (15.9%) 0
Current or former smoker 1456 (18.2%) 1368 (18.0%) 88 (22.2%) 0.04
HOSPITAL EVENTS
AKI in hospital 973 (12.1%) > 20 < 20 0
Invasive ventilation 40 (0.5%) > 20 < 20 0.725
ECMO 552 (6.9%) > 20 < 20 0
COMORBIDITIES
hypertension 3884 (48.5%) 3720 (48.8%) 164 (41.3%) 0.004
heart disease 2659 (33.2%) 2614 (34.3%) 45 (11.3%) 0
neoplasm 2492 (31.1%) 2400 (31.5%) 92 (23.2%) 0.001
chronic respiratory disease 1787 (22.3%) 1704 (22.4%) 83 (20.9%) 0.535
kidney disease 935 (11.7%) > 20 < 20 0
liver disease 849 (10.6%) 822 (10.8%) 27 (6.8%) 0.015
nicotine dependence 759 (9.5%) 734 (9.6%) 25 (6.3%) 0.033
cerebral infarction 327 (4.1%) > 20 < 20 0
dementia 213 (2.7%) > 20 < 20 0.01
arthritis 193 (2.4%) > 20 < 20 0.304